HK1165826A1 - Method for producing dendritic cells - Google Patents

Method for producing dendritic cells

Info

Publication number
HK1165826A1
HK1165826A1 HK12106417.8A HK12106417A HK1165826A1 HK 1165826 A1 HK1165826 A1 HK 1165826A1 HK 12106417 A HK12106417 A HK 12106417A HK 1165826 A1 HK1165826 A1 HK 1165826A1
Authority
HK
Hong Kong
Prior art keywords
dendritic cells
producing dendritic
producing
cells
dendritic
Prior art date
Application number
HK12106417.8A
Other languages
English (en)
Chinese (zh)
Inventor
上田泰次米滿吉和原田結
Original Assignee
生物載體株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 生物載體株式會社 filed Critical 生物載體株式會社
Publication of HK1165826A1 publication Critical patent/HK1165826A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/145—Thrombopoietin [TPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK12106417.8A 2008-11-14 2012-07-03 Method for producing dendritic cells HK1165826A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008292457 2008-11-14
PCT/JP2009/069311 WO2010055900A1 (ja) 2008-11-14 2009-11-13 樹状細胞の製造方法

Publications (1)

Publication Number Publication Date
HK1165826A1 true HK1165826A1 (en) 2012-10-12

Family

ID=42170030

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12106417.8A HK1165826A1 (en) 2008-11-14 2012-07-03 Method for producing dendritic cells

Country Status (7)

Country Link
US (1) US8741639B2 (ja)
EP (1) EP2351599A4 (ja)
JP (3) JP6055165B2 (ja)
KR (1) KR101527260B1 (ja)
CN (1) CN102307989B (ja)
HK (1) HK1165826A1 (ja)
WO (1) WO2010055900A1 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101527260B1 (ko) * 2008-11-14 2015-06-08 디나벡크 가부시키가이샤 수상세포의 제조방법
JP2011239701A (ja) * 2010-05-14 2011-12-01 Tella Inc 樹状細胞の培養方法
EP3520809A1 (en) * 2012-02-03 2019-08-07 Emory University Immunostimulatory compositions.
CN102676455B (zh) * 2012-05-16 2013-05-01 北京和泽普瑞生物科技有限公司 脐带血来源的树突状细胞及树突状细胞疫苗的制备方法
CN103405759B (zh) * 2013-07-23 2014-12-10 蔡颖 一种应用脐血cd34+细胞制备肿瘤特异性dc疫苗方法
JP2014111631A (ja) * 2014-01-31 2014-06-19 Tella Inc 樹状細胞の培養方法
CN104845934B (zh) * 2015-06-08 2018-05-11 河北彤苓榕生物科技有限公司 脐血cd34+造血干细胞来源树突状细胞的大批量制备方法
WO2017065288A1 (ja) * 2015-10-15 2017-04-20 国立大学法人京都大学 多能性幹細胞からｃｄ４陽性ｔ細胞を製造する方法
JP6088633B2 (ja) * 2015-12-24 2017-03-01 株式会社ガイアバイオメディシン 樹状細胞の培養方法
WO2017152008A1 (en) 2016-03-04 2017-09-08 The Trustees Of Columbia University In The City Of New York Development of dual whole cell-based vaccine against pancreatic cancer
JP2018007599A (ja) * 2016-07-12 2018-01-18 株式会社ガイアバイオメディシン 樹状細胞集団の調製方法
JP6426767B2 (ja) * 2017-02-01 2018-11-21 株式会社ガイアバイオメディシン 樹状細胞の培養方法
JP2020077956A (ja) * 2018-11-07 2020-05-21 住友電気工業株式会社 光受信回路
WO2021095700A1 (ja) * 2019-11-12 2021-05-20 学校法人金沢医科大学 樹状細胞分化誘導培地、及び樹状細胞集団の製造方法
CN111019893B (zh) * 2019-12-26 2023-03-03 广东博溪生物科技有限公司 朗格汉斯前体细胞的培养基
CN114107203A (zh) * 2021-12-01 2022-03-01 上海健康医学院 一种dc体外诱导扩增体系及诱导造血干细胞分化为树突状细胞的方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391485A (en) 1985-08-06 1995-02-21 Immunex Corporation DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues
JPH084508B2 (ja) 1987-09-16 1996-01-24 国立予防衛生研究所長 組み換えワクチニアウイルス
JPH0285498A (ja) 1988-09-22 1990-03-26 Dia Consultant:Kk ボーリング孔の採水器
US5108910A (en) 1989-08-22 1992-04-28 Immunex Corporation DNA sequences encoding fusion proteins comprising GM-CSF and IL-3
DE69034258D1 (de) 1989-10-16 2008-09-18 Amgen Inc Stamzellfaktor
TW232710B (ja) 1991-09-13 1994-10-21 American Cyanamid Co
EP0614485B1 (en) 1991-10-23 2002-07-17 Nexell Therapeutics Inc. Methods for selectively expanding cd34 positive cells
JPH05192160A (ja) 1992-01-20 1993-08-03 Banyu Pharmaceut Co Ltd Ｃ型肝炎ウイルスゲノムＲＮＡ、ｃＤＮＡ及びポリペプチド
WO1994002839A1 (en) 1992-07-20 1994-02-03 Scientific Measurement Systems, Inc. A process for analyzing the contents of containers
WO1994008000A1 (en) 1992-10-06 1994-04-14 Akzo Nobel N.V. Pseudorabies virus vaccine
CZ307995A3 (en) 1993-05-24 1996-10-16 Immunex Corp Ligands for flt3 receptors
US5744144A (en) 1993-07-30 1998-04-28 University Of Pittsburgh University Patent Committee Policy And Procedures Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
DE4412794A1 (de) 1994-04-14 1995-12-14 Univ Ludwigs Albert Verfahren zur Herstellung von dendritischen Zellen, so erhaltene Zellen und Behälter zur Durchführung dieses Verfahrens
US6013067A (en) 1995-06-07 2000-01-11 Zymogenetics, Inc. Methods for increasing hematopoietic cells
JP2005102656A (ja) 2003-10-02 2005-04-21 Toray Ind Inc 細胞培養器具およびそれを用いた細胞製剤の製造方法
WO2005042737A1 (ja) 2003-11-04 2005-05-12 Dnavec Research Inc. 遺伝子導入された樹状細胞の製造方法
EP1775343A4 (en) 2004-06-24 2007-11-14 Dnavec Research Inc ANTICANCER AGENTS CONTAINING A DENDRITIC CELL IN WHICH RNA VIRUSES HAVE BEEN TRANSFERRED
CA2504451A1 (en) * 2004-08-10 2006-02-10 Geron Corporation Dendritic cell vaccines for treating cancer made from embryonic stem cells
KR101243577B1 (ko) 2004-10-07 2013-03-20 아고스 쎄라퓨틱스, 인코포레이티드 성숙 수지상 세포 조성물 및 그의 배양 방법
JP2008541762A (ja) * 2005-06-01 2008-11-27 ウイスコンシン アラムナイ リサーチ フオンデーシヨン 胚性幹細胞から樹状細胞を生成する方法
EP2154243B1 (en) 2007-05-17 2016-01-13 ID Pharma Co., Ltd. Method for production of dendritic cell
KR101689124B1 (ko) 2008-03-27 2016-12-23 아스테리아스 바이오세라퓨틱스, 인크. 영장류 다능성 줄기 세포의 조혈계 세포로의 분화
KR101527260B1 (ko) * 2008-11-14 2015-06-08 디나벡크 가부시키가이샤 수상세포의 제조방법

Also Published As

Publication number Publication date
WO2010055900A1 (ja) 2010-05-20
JP6055165B2 (ja) 2016-12-27
CN102307989A (zh) 2012-01-04
KR20110094306A (ko) 2011-08-23
JP2015130881A (ja) 2015-07-23
US8741639B2 (en) 2014-06-03
EP2351599A1 (en) 2011-08-03
JPWO2010055900A1 (ja) 2012-04-12
US20120040458A1 (en) 2012-02-16
JP2017131242A (ja) 2017-08-03
KR101527260B1 (ko) 2015-06-08
JP6182175B2 (ja) 2017-08-16
CN102307989B (zh) 2015-04-22
EP2351599A4 (en) 2013-05-08

Similar Documents

Publication Publication Date Title
ZA201003193B (en) Method for producing dendritic cells
HK1165826A1 (en) Method for producing dendritic cells
EP2277993A4 (en) PROCESS FOR PRODUCING ENDOTHELIAL CELLS (AND VARIANTS)
EP2500418A4 (en) NEW METHOD FOR THE PRODUCTION OF DIFFERENTIATED CELLS
HUE047344T2 (hu) Eljárás szilárd elektrolitos kondenzátorok elõállítására
PL2205354T3 (pl) Sposób wytwarzania biodiesla
EP2463313A4 (en) METHOD FOR MANUFACTURING COPOLYMER
ZA201009116B (en) Method for producing microlenses
PL2252691T3 (pl) Sposób otrzymywania alfa-santalenu
EP2332424A4 (en) PROCESS FOR PRODUCING LIPIDS
EP2154243A4 (en) PROCESS FOR PRODUCING A DENDRITIC CELL
EP2272603A4 (en) METHOD FOR PRODUCING A FORM
EP2474560A4 (en) METHOD OF PREPARING AN 11 SUGAR SIALYLOLIGOSACCHARIDE PEPTIDE
EP2302066A4 (en) METHOD FOR PRODUCING AMINOHYDROXYBENZOIC ACID
PL2432877T3 (pl) Metoda otrzymywania (+) -zizaenu
EP2374789A4 (en) METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE
EP2221306A4 (en) PROCESS FOR PREPARING 2-AZAADAMANTANE
EP2118273A4 (en) METHOD OF MODIFYING CELLS
IL214287A0 (en) Method for producing 2-aminobiphenylene
EP2495312A4 (en) PROCESS FOR GENERATING ANTIGEN-SPECIFIC B-CELL POPULATIONS
EP2311971A4 (en) METHOD FOR PRODUCING HYALURONIC ACID
HK1215590A1 (zh) 生產連續細胞系的方法
IL210051A0 (en) Method for producing aminobiphenylene
EP2357247A4 (en) PROCESS FOR THE PRODUCTION OF POLY-3-HYDROXYALKANOATE
EP2259269A4 (en) METHOD FOR MANUFACTURING RADIOACTIVE STRONTIUM

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20211115